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observed: there were no arrhythmias, no conduction disturbances and no ST-segment 
modifications. Cardiac enzymes remained unchanged. Conclusion: Gadolinium 
enhanced coronary angiography is safe and well tolerated. The mixture of Gadolinium 
with non-ionic contrast allowed us to obtain diagnostic angiograms of excellent quality in 
all cases. In patients at high-risk for renal failure, Gadolinium constitutes an interesting 
adjunct to contrast agents for coronary artery imaging. 
1174-194 Nicorandil, a KATp Channel Opener, Facilitates the 
Recovery of Ventricular Contraction After Reperfusion 
Therapy in Acute Myocardial Infarction: Multicenter 
Registry in Japan 
Sunao Nakamura, Eita Saito, Takanori Miyauchi. Jin Yokoyama, Akihiko Kanazawa. 
Yasufumi Hayama, Koji Hozawa, Shotaro Nakamura, Hitoshi Nakamura, Kazutoshi 
Yamamoto, New Tokyo Hospital, Matsudo-shi, Japan, Kasori Hospital, Chiba-shi, Japan 
To clanfy whether Nicorandil (N) given after acute myccardial infarction (AMI) affects 
subsequent changes in contractile function, we randomized 209 consecutive AMI 
patients hospitalized within 6 hours and gave them either an i.v. drip infusion of 6 mgi 
hour of N (n = 107) or normal saline (S) as control (n = 102) (double blind controlled 
NIMIS trial). No differences existed between the groups in terms of age and gender; 
severity of AMI was also the same as determined by Killip or Forrester classification and 
the left ventriculogram (LVG). One hour before the reperfusion therapy, i.v. infuwn of N 
or S was started and LVG were recorded, as baseline data. Two weeks, 3 months and 
one year later, we repeated the Same tests and compared the results with the baseline 
data. 
Results: The incidence of ventricular arrhythmias (PVCs, VT) and global ejection frac- 
tion were not significantly changed between the groups. However, the regional wall 
motion determined by centerline method after reperfusion therapy was significantly 
greater in N than S group (Figure) and one year cardiac event fee rate was also smaller 
than in N than S group. 
Conclusion: Results suggest that Nicorandil facilitates the recovery of left ventricular 
contractile force in AMI pabents who underwent repeffusion therapy within 6 hours after 
the onset. 
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1174-195 Is Insulin Resistance Associated With One-Year Target 
Vessel Revascularization Rates Results From CREDO 
IRS? 
Steven Marso, Ellen S. McErlean, Eric J. Topol, Steven R. Stelnhubl, Mid America Heart 
Institute, Kansas City, MO 
Insulin Resistance Syndrome (IRS) has been linked with increased neointimal prolifera- 
tion and target vessel revascularization rates in animal models and small human studies. 
CREDO IRS sought to compare one-year target vessel revascularization rates among 
non-diabetic patients undergoing PCI stratified by Homeostasls Model Assessment 
(HOMA). CREDO is a prospective multi-center randomized controlled trial enrolling 
patients undergoing PCI. Patients were randomized to a standard therapy: loading dose 
of placebo and aspirin 325 mg 3.24 hours prior to PCI, 75 mg of clopidogtel within 1 hour 
of PCI. aspirin and clopidogrel 2-26 days, placebo and aspirin 29-365 days, or an 
aggresswe regimen: a loading dose of clopidogrel 300 mg and aspirin 325 mg, 3-24 
hours prior to PCI. 75 mg of clopidog.el within 1 hour of PCI, aspirin and clopidogrel 2- 
365 days. CREDO-IRS was a prospectively designed sub-study. Fasting levels of insulin 
and glucose where measured. Insulin resistance was determined by HOMA tertles. The 
primary endpoint for CREDO-IRS was the need for l-year target vessel revasculawa- 
tion. Other endpoints included the combined’rate of death, MI or revascularization. There 
were 726 patients without a history of type 2 DM eligible for comparison within CREDO 
IRS. These patients were stratified, based on HOMA tertiles. The 26.day events are 
depicted in the table below. The one-year results will be available for presentation. 
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28.Day Events - HOMA Tertiles 
cl.69 1.89-3.36 >3.38 P-value 
N 242 242 242 
DeathlMliUTVR (%) 9.5 7.4 6.3 0.72 
Death (all cause. %) 0.4 0.0 0.0 
Myocardial Infarction (%) 7.4 6.6 7.4 
QMI (%) 1.2 0.8 1.2 
NQM (%) 6.2 5.6 6.2 
Urgent TVR (%) 1.7 0.6 0.8 
1174-196 Temporal Trends of One-Year Reinfarction and Mortality 
Rates Following Primary Angioplasty in High-Risk 
Acute Myocardial Infarction Patients 
Beth A. Bartholomew, Kishore J. Harjai. Judith A. Boura, Srinivas Dukkipati, Michael W. 
Yerkey, Lorelei L. Grines, Bruce R. Brodie, David Cox, Gregg W. Stone, William W. 
O’Neill, Cindy L. Grines, William Beaumont Hospital, Royal Oak, Ml 
Background: The use of primary angioplasty as treatment for acute myocardial infarction 
(AMI) is well established and use has tripled over the last decade. Numerous therapeutic 
advances have been introduced. However, no data exists regarding trends in adverse 
events and long term outcomes for high nsk AMI patients. Methods: Of the 3755 AMI 
patients who had PCI enrolled in the Primary Angioplasty in Myocardial Infarction (PAMI) 
studies from 1990-‘99, 1867 were high risk: heart rate >lOO, anterior infarct, LBBB, sys- 
tolic BP<100 and age over 70. The patients were grouped into 2 ttme periods: ‘90.‘94 
(n=607) and ‘95-‘99 (n=1364). Comparisons of 1 year reinfarction (1 yr reMI) and death 
rates were made between the 2 periods. Reinfarction was defined as recurrent symp- 
toms with any increase in creatine klnase MB fraction above its previous nadir. Multivari- 
ate regression analysis evaluating age >70, gender, EF, Kill@ class >l, systolic BPclOO, 
prior MI, stent use. final stenosis, final dissection, 3 vessel disease, smoking status and 
year enrolled, was used to determine the strongest predictors of 1 yr reMI. Results: 1 yr 
reMl and mortality rates are shown in the table. Year prior to 1995(p<O.O001. OR 3.96) 
and three vessel disease (p-zO.0029, OR 2.06), but not stent use, were independent pre- 
dictors of 1 yr reMI. Conclusions: High risk AMI patients treated with PCI have had a 3 
fold reduction in 1 yr reMl without change in mortality. This is likely attributable to 
improved secondary prevention strategies. 
Reinfarction 
Modality 
‘90.‘94 
9.7% 
6.9% 
‘95.‘99 
2.8% 
8.x 
P value 
<0.0001 
0.12 
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1175-178 Preinterventional Levels of C-Reactive Protein and 
Platelet Function in Patients With Stable Angina 
Nicolas van Beckerath, Olga Gorchakova, Meinrad Gawaz. Julinda Mehilli, Alban Dibra, 
Albert Schomig, Adnan Kastrati, TU Miinchen, Munich, Germany 
Background: Elevated plasma levels of C-reactive protein (CRP) are associated with an 
increased risk of cardiovascular events. Recently, it has been shown that this is alsO true 
for patients with acute coronary syndromes undergoing percutaneous coronary revascu- 
larization. In vitro studies have shown that CRP itself may influence platelet function. 
Methods: Citrated blood samples from 305 consecutive patients with stable angina were 
obtained from the arterial sheath before coronary stenting. All patients had received aspi- 
rin and a loading dose (600 mg) of clopidogrel. CRP plasma levels were determined with 
a high sensitivity assay. Platelet aggregation !n response to ADP, collagen and throm- 
bine activating peptide (TRAP) was measured with lumi-aggregometry, surface expres- 
sion of membrane receptors with flow-cytometry. 
Results: Patients were divided in two groups: CRP > 5 mg/L (n=144) and CRP 6 5m& 
(n=l61). Maximum aggregation (maximum Increase of light transmissvx) in response to 
ADP (5 and 20pM). collagen and TRAP did not differ between the two groups (P values 
0.54, 0.90, 0.40 and 0.83 respectively). In addition, elevated CRP levels were not associ- 
JACC March 19,2003 ABSTRACTS - Angiography & Interventional Cardiology 65A 
ated with enhanced surface expression of glycoprotein (GP) Ilb/llla and P-selectin. In the 
figure, maximum aggregation (ADP ZQIM) is plotted against CRP level. 
Conclusions: In patients with stable angna and combined antiplatelet therapy plasma 
CRP levels do not appreciably correlate with platelet function. 
the first balloon inflation. At the end of the procedure, the coronary flow velocity reserve 
(CFVR=hyperemic APVibaseline APV) was measured after i.c. adenosine (20-4Ol.ig) in 
the recanalized artery. 
Results. During follow-up of 6 months 14 reocclusions (16%) occurred. In patients with 
reocclusion the minimum lumen diameter (MLD) was lower. There was no difference in 
parameters of collateral function, or microvascular function as evidenced by a similar 
CFVR (see Table). The angiographic result remained the best predictor of reocclusion in 
the subgroup analysis of patients with recent and long-term occlusions, and with and 
without regional ventricular dysfunction. 
Conclusion. The risk of reocclusion after recanalization of a TCO was determined by a 
low MLD, but not by the quality of collateral function or microvascular function. 
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1175-179 Preprocedural Levels of C-Reactive Protein, 
Postprocedural Creatin Phosphokinase MB Release, 
and Long-Term Prognosis Following Coronary 
Stenting: Results From the GENERATION Study 
Michael N.&iris, John A. Ambrose, Olga Papadaki, Paraskew Psarogianni, Anastassios 
Lyras, Maria Thoma, Evangelos Tsanis. George Psaltiras, Constantine Fakiolas. 
Evangelos Pissimissis. Christopher Olympios, Stefanos Foussas. Tzanio Hospital, 
Piraeus. Greece, Saint Vincent Hospital, New York, NY 
Background: Elevation of creatin kinase-MB (CK-MB) often occurs after coronary stent- 
ing (CS), but its role on long-term prognosis IS controversial. We evaluated the predictors 
of CK-MB release and Its relationship to long-term outcomes after successful CS in 
patients enrolled in the GENERATION study. 
Methods:The GENERATION study was designed to evaluate, the impact of several 
serum markers (CRP, Lpa. homocystein and seropositivity for chlamydial infection) 
obtained upon admission on the long-term cardiovascular morbidity and mortality and the 
restenosis rate after coronary stenting. For the purpose of this study a total of 463 con- 
secutive patients, treated for stable or unstable coronary syndromes, were recruited 
Complete clinical follow-up was obtained from 465 (96.3%) pts for a period of 3-years. 
Results Of 451 patients with normal pre-intervention CK-MB levels, 39 (391451 6.6%) 
had a peak post-Intervention value >3x normal (without concomitant angina or new elec- 
trocardiographic abnormalities). The number of stents used (p=O.O3), type 8.2 or C 
treated lesions (p=O.OOi) and baseline plasma CRP values (p<O.OOl) were the only sig- 
nificant predictors of CK-MB release. By univariate analysis 3-fold CK-MB release was 
significantly associated with increased risk for the composite endpoint of cardiac death, 
myocardial infarction and rehospitalization for unstable angina (H.R.=2.66, 95%CI=1.62- 
4.37, pcO.001) during the d-years follow up. However, after adjustment for baseline 
plasma CRP values, post-procedural 3.fold CK-MB release did not predict the long-term 
composite endpoint (H.R=0.99 95%Cl=O.53-1.65, p=O.91). 
Conclusion: Elevations in CK-MB following successful CS may reflect the complexity or 
inflammatory status of the treated lesions. These factors may contribute to microembo- 
Ii&ion and subsequent silent myocardial necrosis. Therefore, an increased risk of long- 
term adverse clinical outcomes may be associated with these factors and not the CK-MB 
release per se. 
1175180 Time Relation of the Amount of Macrophages in the 
Plaque During the Chronic Phase of In-Stent Restenosis 
Lodewiik J. Waqenaar, Ad J. van Boven, Allard C. van der Wal, Chris M. van der Loos, 
Rend A. Tio, Anton E. Becker, Wiek H. van Gilst, University Hospital of Groningen, 
Groningen, The Netherlands, Academic Medical Center, Amsterdam, The Netherlands 
Background - Inflammation plays an important role in the acute phase of in-stem resteno- 
sis. But in the chronic phase, after approximately 30 days, the neointimal plaque consist 
mainly of vascular smooth muscle cells. In a previous study, we found that this neointima 
still contains small clusters of macrophages. In this study we Investigated the relation 
between the amount of macrophages in the in-stent restenotic plaque and the time after 
the placement of the stent. Methods - Biopsies from human coronary in-stent restenotic 
lesions were obtained with a pullback atherectomy catheter and immediately frozen in 
liquid nitrogen (n=l9). The time between the placement of the stent and the biopsy varied 
from 69 till 465 days. The biopsies were immunostained for smooth muscle cells, mac- 
rophages and ACE, and a semi-quantitative score was applied: 0 for no macrophages, 1 
for a few or clusters of cells, 2 for <IO% of cells positive, 3 for lo-50% of cells positive 
and 4 for >50% of the cells positive. Results As shown in the figure, an inverse correla- 
tion was found between the amount of macrophages and the time between the biopsy 
and the stent placement (p=O.O13). The macrophages were mostly ACE-positive. There- 
fore, the amount of ACE also decreases during time (p= 0.011). Conclusion - During the 
chronic phase of in-stent restenosis, the amount of macrophages in the neointima 
decreases, as well as the amount of ACE. This Indicates that inflammatory cells play a 
role I” the process of chronic in-stent restenosls. especially in the first phase. 
1175-181 Do Good Collaterals Increase the Risk of Reocclusion 
After Recanalization of a Chronic Coronary Occlusion? 
Gerald S. Werner, Phrlip Bahrmann, Oliver Mutschke. Markds Ferrari, Hans R. Frgulla, 
Friedrich-Schiller Unwersity, Jena, Germany 
Background. The presence of a well developed collateral circulation in chronic coronary 
occlusions (TCO) is considered a potential determinant of reocclusion. The present study 
directly assessed collateral circulation at the time of recanalizatlon by i.c. Doppler and 
pressure recordings I” order to relate it to the risk of reocclusion. 
Methods. In 96 consecutive patients a TCO (duration >2 weeks) was recanalized with 
stenting. Before PTCA average peak velocity distal to the occlusion (APVo). distal coro- 
nary pressure (Po) and aoriic pressure (PAo) were measured, and a collateral resistance 
Index (RcoI, =(P,,-Po)/APVo) was calculated. Collateral function was assessed before 
Reocclusion No reocclusion p-value 
RCa,, [mmHg’cm_ 7.9i4.6 7.5+5.5 0.63 
1 fgl 
CFVR 1.92+0.62 1.96+0.56 0 72 
MLD [mm] 1.91*0.37 2.27t0.51 0.015 
1175-162 Enhanced Suppression of Inflammation After Coronary 
Stenting (ESIS): A Randomized Clinical Trial Comparing 
Abciximab and Eptifibatide 
Atul Aqqarwal, David J. Schneider, Edward F. Terrien, Christopher M. Terrien, Ill, 
Matthew W. Watkins, Samer S. Kabbani, Harold L. Dauerman, University of Vermont 
College of Medicine, Burlington, VT 
Background: Inflammation after coronary stenting portends adverse outcomes. Abcix- 
imab (A) and eptifibatide (E) are reported to alter inflammation after coronary intervention 
but no randomized trial has compared their efficacy. We compared the effect of A and E 
on inflammation after stenting. 
Methods: Patients undergoing coronary stentlng were randomized to treatment with A 
(n=24) or E (n=26). Blood samples were obtained before stenting. and after IO min, 1 hr 
and 16-24 hr. C-reactive protein (CRP.pg/ml), interleukin-6 (IL-6, pglml) and interleukin- 
1 receptor antagonist (IL-1Ra. pglml) were measured by ELISA. Changes in each marker 
after treatment with A or E were analyzed by repeated measure analysis of variance. 
Logarithmic transformation was performed to limit effects of inter-individual variability 
Results: Of the 50 patients enrolled, 66% had acute coronary syndromes. The groups (A 
and E) had similar clinical features, and baseline values of CRP, IL-6, and IL-1 Ra. CRP, 
IL-6 and IL-1Ra increased after stenting despite administration of A or E (see table) and 
comparable increases were seen after each treatment. After logarithmic transformation, 
greater suppression in IL-1Ra but not CRP or IL-6 was seen after E compared with A 
(p=0.03). 
Conclusions: In this randomized trial, inflammation after coronary stenting persists 
despite treatment with A or E. A uniform benefit of one agent wer the other was not 
seen. Enhanced suppressron of inflammation after stenting is a potential therapeutic tar- 
get. 
Before Stenting 10 mrnutes 1 hour 16-24 hours p-value for trend 
CRP (A) 10*19 6.9*16 10+16 13*15 <0.0001 
CRP (E) 6.2+14 6.9*13 10*14 12+15 <0.0001 
IL-6 (A) 5.9t7.4 6.9i8.3 10*12 23i30 <0.0001 
IL-6 (E) 6.7~14 7.6+15 12+21 22i23 <0.0001 
IL-I Ra (A) 546+324 603+310 760+403 672i264 0.0003 
IL-1 Ra (E) 646+496 666+566 711*590 663*505 0.0003 
1175-183 Preprocedural C-Reactive Protein Levels Are Not 
Associated With Restenosis After Successful Coronary 
Stenting: Results From the GENERATION Study 
Michael N. Zairi$ John A. Ambrose, Olga Papadaki, Alexander Stefanidis. Denis Vitalis, 
Stavros Manousakis, Demetrw Petropoulos, Evangelos Tsanis, Evangelos Pissimissis, 
Christopher Olympios. Denis Cokkinos, Stefanos Foussas, Tzamo Hospital, Piraeus, 
Greece, Saint Vincent Medical Centers, Manhattan. New York, NY 
BACKGROUND High plasma C-reactive protein (CRP) levels, has been associated with 
adverse prognosis in pts with coronary artery disease. However, the impact of preproce- 
dual CRP levels on the rate of in-stent restenosis (ISR) after succesful coronary stenting 
(CS) has not been clarified. METHODS The GENERATION study was designed to evaI- 
uate. the impact of several serum markets estimated upon admittance (CRP, Lpa, 
homocystein and seropositivity for chlamydial infection) on the long-term prognosis and 
ISR rate after CS. For the purpose of this study a total of 463 consecutive pabents who 
underwent successful CS due to stable or unstable coronary syndromes were recruited. 
Complete clinical follow up was obtained from 465 (96.3%) pts in a period of 3-years. 
Results: By l-year, 121 patients (121/465 24.1%) developed recurrence of SymptOms. 
During this l-year time period, 309 (309/465 66.5%) patients underwent angiographic 
restudy, tncluding 114 (1 14/121 94.2%) symptomatic and 195 (195/344 55.1%) asymp- 
tomatic. Pts were classified into four groups according to the quartiles of CRP values. 
ISR was observed in 106 (106/309 35%) pts. The distribution of restenosis among the 
quartiles of CRP is presented in the table. There was no statistically increased risk of ISR 
with increasing of CRP quartiles (P=O.69) 
